Sanzyme Biologics is a group company of Sanzyme Private Limited (Founded as Uni-Sankyo in 1969, first Indo-Japanese joint venture). Sanzyme is a pioneer in fermentation technology with 50 years of legacy in the area of probiotics. It was the first company to launch probiotics in India and today a market leader with presence in over 35 countries across the globe including key markets such as US, Europe, Japan, South Korea, Australia, New Zealand and Taiwan.
Sanzyme manufactures aerobic spore formers (Bacillus), aerobic vegetative strains (Lactobacillus) and yeasts (Saccharomyces) in its world class facility at Hyderabad, India. It adopts proprietary technology and has a sound selection of strains meeting global standards.
Its flagship Bacillus Coagulans SNZ1969 strain is an aerobic spore-forming, lactic acid-producing probiotic bacteria. It has the answer to the critical stability challenges associated with vegetative probiotic organisms. SNZ1969 spores are robust and offers flexibility to food, supplement, and pharma product formulators. It sustains processing conditions, gut pH, bile salt and does not require cold chain. It has US FDA GRAS (including infants) and supported with 25 plus scientific publications around gut health, oral health, and women’s health.
- Bacillus coagulans SNZ 1969
- Bacillus clausii SNZ 1971
- Bacillus subtilis SNZ 1972
- Saccharomyces boulardii SNZ 1986